CLDX
Price
$18.33
Change
-$1.19 (-6.10%)
Updated
May 9 closing price
Capitalization
1.22B
89 days until earnings call
VIGL
Price
$2.42
Change
+$0.01 (+0.41%)
Updated
May 9 closing price
Capitalization
112.95M
94 days until earnings call
Ad is loading...

CLDX vs VIGL

Header iconCLDX vs VIGL Comparison
Open Charts CLDX vs VIGLBanner chart's image
Celldex Therapeutics
Price$18.33
Change-$1.19 (-6.10%)
Volume$1M
Capitalization1.22B
Vigil Neuroscience
Price$2.42
Change+$0.01 (+0.41%)
Volume$151.8K
Capitalization112.95M
CLDX vs VIGL Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. VIGL commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and VIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (CLDX: $18.33 vs. VIGL: $2.42)
Brand notoriety: CLDX and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 125% vs. VIGL: 95%
Market capitalization -- CLDX: $1.22B vs. VIGL: $112.95M
CLDX [@Biotechnology] is valued at $1.22B. VIGL’s [@Biotechnology] market capitalization is $112.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, VIGL is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while VIGL’s TA Score has 6 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 5 bearish.
  • VIGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а -11.28% price change this week, while VIGL (@Biotechnology) price change was -12.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.22B) has a higher market cap than VIGL($113M). VIGL YTD gains are higher at: 42.353 vs. CLDX (-27.463). VIGL has higher annual earnings (EBITDA): -89.23M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. VIGL (97.8M). CLDX has less debt than VIGL: CLDX (3.81M) vs VIGL (12.9M). CLDX has higher revenues than VIGL: CLDX (7.02M) vs VIGL (0).
CLDXVIGLCLDX / VIGL
Capitalization1.22B113M1,077%
EBITDA-191.9M-89.23M215%
Gain YTD-27.46342.353-65%
P/E RatioN/AN/A-
Revenue7.02M0-
Total Cash725M97.8M741%
Total Debt3.81M12.9M30%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXVIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-6.10%
BEAM - CLDX
53%
Loosely correlated
+0.93%
KYMR - CLDX
51%
Loosely correlated
-2.27%
DNLI - CLDX
51%
Loosely correlated
-0.42%
NTLA - CLDX
50%
Loosely correlated
-1.93%
RVMD - CLDX
49%
Loosely correlated
-3.56%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with ELVN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
+0.41%
ELVN - VIGL
37%
Loosely correlated
-1.13%
ALEC - VIGL
37%
Loosely correlated
+12.50%
CLDX - VIGL
36%
Loosely correlated
-6.10%
RCKT - VIGL
36%
Loosely correlated
-0.71%
DNLI - VIGL
35%
Loosely correlated
-0.42%
More